Replies to post #63819 on NorthWest Biotherapeutics Inc (NWBO)

[TC_Trader]

Yes I'm here. I find this kind of interesting. 40% of the volume MTD is by UBS. Normal. Second most is Northland Securities. Odd. They are not that big a player in market making. Their director of biotechnology analysis is Dr. Mark Landy who was once at Summer Street. Anyone who has been here since 2014 or earlier may remember Summer Street was one of the few buy side analysts to put out lofty price targets on NWBO and recommend them as a buy.

Case in point:
http://www.streetinsider.com/Analyst+Comments/Northwest+Biotherapeutics+(NWBO)+Target+Lifted+to+$15.10+at+Summer+Street/9269427.html

I'd like to see how this gets spun...those are just facts.

Oh, and I've been told that the Summer Street analyst mentioned in the above, Carol, quit the industry because she was receiving threats. Those comments can be found in my posting history in a comment I made to AF shortly after he arrived here. He didn't deny it, he said something like "welcome to the club."